View Latest Issue
Initiating allopurinol treatment during an acute gout attack does not worsen the attack or adversely affect resolution of the attack.
Although gout is associated with an increased risk of cardiovascular and renal disease, a population-based study suggests that gout may reduce the risk of developing Alzheimer’s disease (AD).
The first blood test to detect early-stage osteoarthritis (OA) appears to be in sight, according to research published online recently in Scientific Reports.
The literature is conflicting regarding the value of intra-articular hyaluronate injections for the treatment of knee osteoarthritis (OA).
Microglia may serve a protective purpose for the masses, but for those who suffer from fibromyalgia, these adaptive cells of the central nervous system are the enemy—the source of constant flu-like sickness and pain.
Change comes at a price. While there is little doubt that biologics have changed the landscape of therapy in rheumatic diseases, they have also raised the costs of healthcare in the process.
In the rapidly evolving field of medicine, what may seem esoteric today could be standard of care tomorrow.
The power of technology is driving breakthroughs in medicine with advances in genomics, proteomics, metabolomics, and informatics, to name just a few.
Despite early and aggressive intervention, remission rates remain low for rheumatology patients; damage is often progressive, morbidity and mortality are significant, and socioeconomic decline is an ongoing concern.
An analysis of a theoretical cohort of patients using a mathematical model suggests that it is cost-effective for morbidly obese individuals to have bariatric surgery prior to total hip arthroplasty (THA), compared with having hip-replacement surgery alone.
Page 2 of 3
Results 11 - 20 of 27
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology